XOMA Acquires Royalty Interest Position in Six Clinical-Stage Assets

NEXT STORY
Plus Therapeutics, Inc. Announces Closing of $15 Million Underwritten Public Offering
PREV STORY
Stemline Therapeutics to Present at the 2019 Cantor Global Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Spectral Medical’s Wholly-Owned Subsidiary Dialco Medical Announces DIMI Usability Trial Posted on the ClinicalTrials.gov Website

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech has delivered the first batch of FIT-06 vaccine to EHVA clinical trials

FIT Biotech Oy                                                                                                                                                                                                           Press release 27.8.2018 at 08.30 AM EET FIT Biotech ...

author_avatar
NASDAQ Market News

Uveitis Therapeutics Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments: Pharma Proff

author_avatar
NASDAQ Market News